Trial Profile
Effect of Istradefylline on non-motor symptoms (NMS) in patients with Parkinson's disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Istradefylline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 11 Dec 2015 New trial record